TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year debt growth rate

Percentile
P17
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2025-3.33%
20245.35%
20237.50%
20221322.87%
2021-18.71%
202052.12%
20190.00%